Monograph Details
|
|
Eye Disorders
> Ocular allergy/inflammation
|
|
VEXOL |
| Manufacturer |
|
Alcon Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Steroid. |
| Generic Name |
|
Rimexolone 1%; oph susp; contains benzalkonium chloride. |
| Indications |
|
Post-op inflammation. Anterior uveitis. |
| Children |
|
Not recommended. |
| Adults |
|
Post-op: 1–2 drops into conjunctival sac(s) 4 times daily; start 24 hrs after surgery and continue through 1st 2 weeks post-op. Uveitis: 1–2 drops into the conjunctival sac(s) every hour while awake for 1st week, then 1 drop every 2 hrs while awake for 2nd week, then taper until resolved. |
| Contraindications |
|
Epithelial herpes simplex keratitis and other viral infections including vaccinia, varicella. Ocular mycobacterial, fungal, or untreated purulent infections. |
| Precautions |
|
Corneal or scleral thinning. Monitor intraocular pressure. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Adverse Reactions |
|
Blurred vision, discharge, discomfort, ocular pain, increased intraocular pressure, foreign body sensation, hyperemia, pruritus; may mask secondary ocular infections; ocular hypertension/glaucoma, optic nerve damage, defects in visual acuity and visual fields, posterior subcapsular cataract formation, superinfection possible with prolonged use. |
| How Supplied |
|
Susp—5mL, 10mL |
|
|
|
|
